Treace Medical Concepts Inc

TMCI

1.220USD

-0.060-4.69%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

Treace Medical Concepts Inc's Score

Industry at a Glance

Industry Ranking

120 / 208

Overall Ranking

282 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Treace Medical Concepts Inc Highlights

StrengthsRisks

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 212.69M.

Overvalued

The company’s latest PE is -1.31, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 38.98M shares, decreasing 28.47% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 4.87K shares of this stock.

Analyst Rating

Based on 5 analysts

Hold

Current Rating

4.000

Target Price

+212.50%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Treace Medical Concepts Inc is 6.91, ranking 101 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 62.52M, representing a year-over-year decrease of 9.01%, while its net profit experienced a year-over-year decrease of 1775.05%.

Score

Industry at a Glance

Previous score

6.91

Change

0



Financials

5.29

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.40

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.37

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.22

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.27

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Treace Medical Concepts Inc is 7.21, ranking 111 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -1.31, which is 0.00% below the recent high of -1.31 and -2593.85% above the recent low of -35.24.

Score

Industry at a Glance

Previous score

7.21

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 120/208

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Treace Medical Concepts Inc is 6.00, ranking 175 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 5.00, with a high of 7.50 and a low of 4.00.

Score

Industry at a Glance

Previous score

6.00

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Treace Medical Concepts Inc is 5.56, ranking 177 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.67 and the support level at 0.98, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.99

Change

-0.43

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Treace Medical Concepts Inc is 5.00, ranking 114 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 61.18%, representing a quarter-over-quarter increase of 1.78%. The largest institutional shareholder is The Vanguard, holding a total of 2.27M shares, representing 3.52% of shares outstanding, with 18.16% decrease in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Treace (John T.)

11.70M

-1.34%

Armistice Capital LLC

6.32M

+0.89%

Gagnon Securities LLC

2.26M

+0.36%

BlackRock Institutional Trust Company, N.A.

3.26M

-0.80%

The Vanguard Group, Inc.

Star Investors

2.73M

+0.23%

Treace (James T)

1.78M

--

Gagnon Advisors, LLC

968.46K

+16.64%

Millennium Management LLC

1.71M

+12.72%

CIBC Private Wealth Advisors, Inc.

1.69M

-0.06%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Treace Medical Concepts Inc is 2.52, ranking 154 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.88. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Treace Medical Concepts Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Treace Medical Concepts Inc

TMCI

5.87 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bioventus Inc

BVS

8.28 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.13 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.07 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Edwards Lifesciences Corp

EW

8.05 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment